Living with Scleroderma

Recent Posts

• Efzofitimod found safe, well tolerated in study of SSc-ILD
• Study shows immune signaling protein IL-40 is also involved in SSc
• First SSc patient dosed in Phase 1 trial of CAR T-cell therapy
• National Scleroderma Foundation recognizes outstanding chapters
• Developing a plan is helpful when dealing with medical uncertainty
• SRF joins capital effort to advance drug development for scleroderma
• Scientists ID 4 SSc-ILD subtypes to better predict patient outcomes
• Phase 2 trial testing nemolizumab for SSc slated to launch soon
• Immune cells linked to kidney, lung complications in SSc: Study
• Why scleroderma awareness is important to me